MCE 的所有产品仅用作科学研究，我们不为任何个人用途提供产品和服务。

L-Leucine

CAS No. : 61-90-5

MCE 站：L-Leucine

产品活性：L-Leucine 是一种必需的支链氨基酸 (BCAA)，可激活 mTOR 信号通路。

研究领域：PI3K/Akt/mTOR

作用靶点：mTOR

In Vitro: L-Leucine (10 mM) treatment impairs endocrine progenitor cell development.
In E13.5 rat pancreatic explants, in absence of added L-Leucine, Ngn3 mRNA levels increased after 1 day of culture, peaked on day 3, and then decreased. When L-Leucine is added, a dramatic decrease is observed in Ngn3 mRNA levels. This decrease in Ngn3 mRNA levels was paralleled by a decrease in the number of Ngn3-expressing cells (4728±408 vs. 959±28; P<0.01). Finally, L-Leucine also caused a dose-dependent repressive effect on the mRNA levels of the three genes, namely Ngn3, its target Insm1, and insulin.
Leucine stimulates protein synthesis in skeletal muscle of neonatal pigs by enhancing mTORC1 activation. L-Leucine increases intracellular HIF-1α levels and activates the HIF-1α signaling pathway, and these two effects are mediated by the mTOR signaling pathway. This process results in Ngn3 repression and, consequently, decreases β-cell differentiation.

In Vivo: L-Leucine (24 g/kg diet) combined with Resveratrol (12.5 mg/kg diet) to diet-induced obese (DIO) mice increases adipose Sirt1 activity.
Combination results in significant reductions in body weight, weight gain, visceral adipose tissue mass, fat oxidation and heat production in mice.

相关产品：Fragment Library  |  FDA-Approved Drug Library Plus  |  Drug Repurposing Compound Library  |  Natural Product Library Plus  |  FDA-Approved Drug Library Mini  |  Anti-Aging Compound Library  |  Antioxidants Compound Library  |  Orally Active Compound Library  |  Kinase Inhibitor Library  |  Oxygen Sensing Compound Library  |  Natural Product Library  |  Glutamine Metabolism Compound Library  |  FDA-Approved Drug Library  |  PI3K/Akt/mTOR Compound Library  |  Glycolysis Compound Library  |  Drug Repurposing Compound Library Plus  |  NMPA-Approved Drug Library  |  Bioactive Compound Library Plus  |  Autophagy Compound Library  |  FDA Approved & Pharmacopeial Drug Library  |  Cytoskeleton Compound Library  |  Diabetes Related Compound Library  |  Rapamycin  |  Everolimus  |  Torin 1  |  MHY1485  |  AZD-8055  |  Sapanisertib  |  Dactolisib  |  Temsirolimus  |  Vistusertib  |  3BDO  |  PI-103  |  LY3023414  |  JR-AB2-011  |  Torin 2  |  Salidroside  |  Torkinib  |  PF-04691502  |  Omipalisib  |  OSI-027  |  Gedatolisib  |  Dihydromyricetin  |  Deforolimus  |  KU-0063794  |  Apitolisib  |  GDC-0084  |  Bimiralisib  |  Voxtalisib  |  CC-115  |  PQR620

品牌介绍:
•   MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供*新*全的高品质小分子活性化合物；
•   10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种期刊及制药收录了MCE客户的科研成果；
•   专业团队跟踪*新的制药及生命科学研究进展，为您提供全球*新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。